Sunlight AI announces $17.4 million seed round and Bradford acquisition
The company lists New York and Miami as its bases and is building administrative services for independent physicians. Its first announced acquisition accompanies funding led by Lan Xuexhao, founder of Basis Set Ventures.
Key Takeaways
- •Sunlight AI announced $17.4 million in seed funding and its acquisition of Bradford Medical Associates.
- •The company aims to provide administrative support while preserving physician ownership and clinical control.
- •Miami is a stated company base; no local hiring target or physician-client rollout was disclosed.
Sunlight AI, which describes itself as based in New York and Miami, has announced $17.4 million in seed funding and the acquisition of Bradford Medical Associates as it builds services for independent physician practices.
The company disclosed the launch in an October 19 announcement. Founder and CEO Sina Chehrazi is positioning Sunlight as an operating partner for doctors who want help running their businesses while retaining ownership and clinical control.
The round is led by Lan Xuexhao, founder of Basis Set Ventures. Named participants include Sofeon Ventures, Social Leverage, Actions Capital, Overlook Ventures and Early Light Ventures, alongside healthcare investors, family offices and technology founders.
An administrative-services strategy
Sunlight's service offering spans billing, human resources and payroll, and tax and finance work, according to the company materials reviewed for the announcement. Its stated approach combines technology with human expertise rather than assigning every administrative task to a physician or office manager.
Bradford is the first acquisition identified in the launch announcement. Sunlight says it intends to add further service providers working with independent doctors. It did not disclose a purchase price or a detailed schedule for those additional transactions.
For practice owners, the distinction between buying administrative support and selling a medical practice is central to Sunlight's pitch. The company says its model preserves physician ownership. The acquisition announcement concerns a service provider; it does not establish that Sunlight has bought a Miami clinic or taken over local patient care.
A market already changing
The American Medical Association's Physician Practice Benchmark Survey provides a separate measure of the ownership changes facing this market. Its analysis found that 42.2% of physicians worked in private practices in 2024, compared with 60.1% in 2012.
The AMA describes a shift toward larger organizations and practices owned by hospitals or other entities. Its research identifies inadequate payment rates, costly resources and regulatory and administrative requirements as longstanding reasons practices are sold. Those findings establish the wider business pressure, rather than evidence that any one vendor can reverse it.
The benchmark surveys have run every other year since 2012 and focus on physicians providing patient care for at least 20 hours a week who do not work for the federal government. The figures describe a defined national physician population. They are not a count of Miami practices or a measurement of Sunlight's customers.
That distinction matters when evaluating an administrative platform. A funding round measures capital committed to a business; it does not measure time saved in an office, better insurance collections or improved clinical outcomes. A practice considering this type of service would still need to compare the offered scope, fees and actual results with its existing arrangements.
Miami connection and next steps
Miami is one of the two cities Sunlight names in its company description. The reviewed announcement does not provide a Miami hiring target, identify local physician clients or set a timetable for a South Florida rollout. The local news is the city's place in the company's stated operating footprint, alongside the newly announced financing.
The next concrete milestones are additional identified acquisitions and details showing how the services are delivered to practices. Until those emerge, the funding and Bradford transaction remain the verified developments, while the promised operational benefits remain the company's proposition.






